The Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Crosstalk Between Oxidative Stress and M1/M2 Microglial Polarization Following Ischemic Stroke.

Authors

Weizhuo Lu, Zenghong Jiang, Shuangling Li, Ling Xu, Jiyue Wen

Published in

Molecular neurobiology. Volume 63. Issue 1. Jun 15, 2026. Epub Jun 15, 2026.

Abstract

Ischemic stroke, a major contributor to global disability and mortality, results from the disruption of cerebral blood flow. The efficacy of recanalization therapy, the primary intervention for ischemic stroke, is often compromised by cerebral ischemia/reperfusion (I/R) injury. A critical factor in this pathological process is microglial polarization: M1 phenotypic microglia aggravates cerebral I/R injury, whereas the M2 phenotype supports neuroprotection and tissue repair. Consequently, shifting microglial polarization toward the M2 phenotype has emerged as a promising strategy to reduce early ischemic damage. Additionally, energy failure during ischemia leads to excessive generation of reactive oxygen species (ROS), causing oxidative stress, a key mechanism underlying cerebral I/R injury. Oxidative stress is strongly linked to M1 microglial activation, which further amplifies ROS production. In contrast, suppressing oxidative stress can promote the polarization of microglia toward the M2 phenotype, which is characterized by enhanced antioxidant capacity. Nuclear factor erythroid 2-related factor 2 (Nrf2), a central transcriptional regulator of antioxidant defense, coordinates multiple signaling pathways that concurrently alleviate oxidative stress and encourage M2 microglial polarization. Hence, Nrf2 acts as a crucial mediator in the interplay between oxidative stress and M1/M2 microglial polarization. This review outlines the current understanding of oxidative stress and microglial polarization in cerebral I/R injury, highlights the central role of Nrf2 in regulating their crosstalk, and suggests novel therapeutic approaches to mitigate cerebral I/R injury.

PMID:
42295478
Bibliographic data and abstract were imported from PubMed on 15 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.